Format

Send to

Choose Destination
See comment in PubMed Commons below
Mol Oncol. 2010 Dec;4(6):482-95. doi: 10.1016/j.molonc.2010.09.004. Epub 2010 Sep 26.

Phosphoproteomics in cancer.

Author information

1
Institute of Bioinformatics, International Technology Park, Bangalore, India. harsha@ibioinformatics.org

Abstract

Reversible protein phosphorylation serves as a basis for regulating a number of cellular processes. Aberrant activation of kinase signaling pathways is commonly associated with several cancers. Recent developments in phosphoprotein/phosphopeptide enrichment strategies and quantitative mass spectrometry have resulted in robust pipelines for high-throughput characterization of phosphorylation in a global fashion. Today, it is possible to profile site-specific phosphorylation events on thousands of proteins in a single experiment. The potential of this approach is already being realized to characterize signaling pathways that govern oncogenesis. In addition, chemical proteomic strategies have been used to unravel targets of kinase inhibitors, which are otherwise difficult to characterize. This review summarizes various approaches used for analysis of the phosphoproteome in general, and protein kinases in particular, highlighting key cancer phosphoproteomic studies.

PMID:
20937571
PMCID:
PMC3030978
DOI:
10.1016/j.molonc.2010.09.004
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley Icon for PubMed Central
    Loading ...
    Support Center